US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1    3    5  6  7  8  9  10  
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... information on the therapeutics under development for Retinitis Pigmentosa (Retinitis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ...  |  read more...
USD 2,000
Retinopathy - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... for Retinopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Myocardial Fibrosis - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... therapeutics under development for Myocardial Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... III (MPS III) (Sanfilippo Syndrome ) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ), complete with analysis by stage of development, drug target, ...  |  read more...
USD 2,000
Medulloblastoma - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... for Medulloblastoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... I (MPS I) (Hurler Syndrome ) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ), complete with analysis by stage of development, drug target, ...  |  read more...
USD 2,000
Liposarcoma - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... for Liposarcoma , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its ...  |  read more...
USD 2,000
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections, complete with analysis by stage of development, drug target, ...  |  read more...
USD 2,000
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutics under development for Liver Failure (Hepatic Insufficiency), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The ...  |  read more...
USD 2,000
Poliomyelitis - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... for Poliomyelitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pituitary ACTH Hypersecretion (Cushing Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ...  |  read more...
USD 2,000
Streptococcal Pneumonia - Pipeline Review, H1 2016
6/8/2016 | published by: Global Markets Direct
... therapeutics under development for Streptococcal Pneumonia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Pertussis (Whooping Cough) - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... information on the therapeutics under development for Pertussis (Whooping Cough), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the ...  |  read more...
USD 2,000
Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... Arthritis (Still Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), ...  |  read more...
USD 2,000
Smoking Addiction - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... therapeutics under development for Smoking Addiction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Streptococcal Infections - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... therapeutics under development for Streptococcal Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Gaucher Disease - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... therapeutics under development for Gaucher Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Neurofibromatoses - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... for Neurofibromatoses, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Lassa Fever - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... therapeutics under development for Lassa Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H1 2016’, provides in depth analysis on C-C Chemokine Receptor Type 5 (C-C CKR-5 or CHEMR13 or HIV-1 Fusion Coreceptor or CD195 or ...  |  read more...
USD 3,500
Corticosteroid 11-Beta-Dehydrogenase Isozyme 1 (11-Beta-Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or 11-DH or 11-beta-HSD1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... 11-Beta-Dehydrogenase Isozyme 1 (11-Beta-Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or 11-DH or 11-beta-HSD1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2016’, provides in depth analysis on Corticosteroid 11-Beta-Dehydrogenase ...  |  read more...
USD 3,500
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016
6/15/2016 | published by: GlobalData
... trials scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the ...  |  read more...
USD 2,500
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016
6/15/2016 | published by: GlobalData
... of Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer. Report includes an overview of ...  |  read more...
USD 2,500
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... II (MPS II) (Hunter Syndrome ) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ), complete with analysis by stage of development, drug target, ...  |  read more...
USD 2,000
Systemic Idiopathic Juvenile Arthritis - Pipeline Review, H1 2016
6/15/2016 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutics under development for Systemic Idiopathic Juvenile Arthritis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The ...  |  read more...
USD 2,000
1    3    5  6  7  8  9  10